Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus in Los Angeles
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Necrotizing fasciitis is a life-threatening infection requiring urgent surgical and medical therapy. Staphylococcus aureus has been a very uncommon cause of necrotizing fasciitis, but we have recently noted an alarming number of these infections caused by community-associated methicillin-resistant S. aureus (MRSA). METHODS: We reviewed the records of 843 patients whose wound cultures grew MRSA at our center from January 15, 2003, to April 15, 2004. Among this cohort, 14 were identified as patients presenting from the community with clinical and intraoperative findings of necrotizing fasciitis, necrotizing myositis, or both. RESULTS: The median age of the patients was 46 years (range, 28 to 68), and 71 percent were men. Coexisting conditions or risk factors included current or past injection-drug use (43 percent); previous MRSA infection, diabetes, and chronic hepatitis C (21 percent each); and cancer and human immunodeficiency virus infection or the acquired immunodeficiency syndrome (7 percent each). Four patients (29 percent) had no serious coexisting conditions or risk factors. All patients received combined medical and surgical therapy, and none died, but they had serious complications, including the need for reconstructive surgery and prolonged stay in the intensive care unit. Wound cultures were monomicrobial for MRSA in 86 percent, and 40 percent of patients (4 of 10) for whom blood cultures were obtained had positive results. All MRSA isolates were susceptible in vitro to clindamycin, trimethoprim-sulfamethoxazole, and rifampin. All recovered isolates belonged to the same genotype (multilocus sequence type ST8, pulsed-field type USA300, and staphylococcal cassette chromosome mec type IV [SCCmecIV]) and carried the Panton-Valentine leukocidin (pvl), lukD, and lukE genes, but no other toxin genes were detected. CONCLUSIONS: Necrotizing fasciitis caused by community-associated MRSA is an emerging clinical entity. In areas in which community-associated MRSA infection is endemic, empirical treatment of suspected necrotizing fasciitis should include antibiotics predictably active against this pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343
Research works printed but not linked: 6
- 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- Headley AJ, 2003, Am Fam Physician, 68, 323
- Wu KC, 2002, J Microbiol Immunol Infect, 35, 53
- 2003, MMWR Morb Mortal Wkly Rep, 52, 793
- Perdreau-Remington F, Pan E, Carleton H, Diep B, Harvey S, Sensabaugh G. Staphylococcus aureus infections in Northern and Southern California jails in 2002 due to a single clone carrying Panton-Valentine leukocidin. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 14–17, 2003. Washington, D.C.: American Society for Microbiology, 2003:382. abstract.
- 2003, MMWR Morb Mortal Wkly Rep, 52, 992
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citationStevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
“pyogenes or, far less commonly, community-acquired MRSA [108].”
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Methicillin-resistant Staphylococcus aureus
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,556
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Self-citationDiep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Self-citationLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
“ropharyngeal abscess [12–15].”
Self-citationPractice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
“Recently, necrotizing fasciitis was described in a patient with MRSA infection [7].”
BackgroundCommunity-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
“However, recently there has been an alarming epidemic caused by community-associated (CA)-MRSA strains, which can cause severe infections that can result in necrotizing fasciitis or even death in otherwise healthy adults outside of healthcare setting”
BackgroundPathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
“These have included cases of necrotizing fasciitis caused by PFGE type USA300 [67], as well as cases of pyomyositis [68, 69], purpura fulminans with toxic shock syn-”
BackgroundGorwitz, R. J., Kruszon‐Moran, D., McAllister, S. K., McQuillan, G., McDougal, L. K., Fosheim, G. E., Jensen, B. J., Killgore, G., Tenover, F. C., & Kuehnert, M. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/533494 · Cited by 926
Necrotizing Soft-Tissue Infections
Stevens, D. L., & Bryant, A. E. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1600673 · Cited by 828
Necrotizing Soft-Tissue Infection: Diagnosis and Management
Goldstein, E. J. C., Anaya, D. A., & Dellinger, E. P. (2007) · Clinical Infectious Diseases · doi:10.1086/511638 · Cited by 862
“More recently, NSTI without a recognized precipitating factor has also been identified with community-acquired methicillin-resistant staphylococcal infection [14].”
BackgroundEpidemiology of Methicillin‐Resistant Staphylococcus aureus
Boucher, H. W., & Corey, G. R. (2008) · Clinical Infectious Diseases · doi:10.1086/533590 · Cited by 805
“These include necrotizing fasciitis [59], Waterhouse-Friderichsen syndrome [60], empyema [61], postinfluenza pneumonia [33, 62], septic thrombophlebitis [58], pyomyositis with or without osteomyelitis or septic arthritis [63, 64], and bacteremia [57].”
BackgroundSeybold, U., Kourbatova, E. V., Johnson, J. G., Halvosa, S. J., Wang, Y. F., King, M. D., Ray, S. M., & Blumberg, H. M. (2006) · Clinical Infectious Diseases · doi:10.1086/499815 · Cited by 695
“More recently, cases of necrotizing pneumonia and necrotizing fasciitis have been linked to PVL-producing MRSA strains [21, 24].”
BackgroundOtto, M. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.11.004 · Cited by 643
“aureus as the causative agent [1,2].”
Necrotizing Fasciitis: Current Concepts and Review of the Literature
Sarani, B., Strong, M., Pascual, J., & Schwab, W. C. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.10.032 · Cited by 594
Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils
Voyich, J. M., Braughton, K. R., Sturdevant, D. E., Whitney, A. R., Saïd-Salim, B., Porcella, S. F., Long, R. D., Dorward, D. W., Gardner, D. J., Kreiswirth, B. N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3907 · Cited by 563
“In contrast, MRSA252 is a leading cause of hospital infections in the United States and United Kingdom (16), but to our knowledge is not a typical source of disease in individuals without associated risk factors.”
BackgroundInfluentialVoyich, J. M., Otto, M., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D., Long, R. D., Dorward, D. W., Gardner, D. J., Lina, G., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509506 · Cited by 565
“The widespread increase in the severity of CA-MRSA disease correlates generally with infection by strains that contain PVL [3, 10, 11, 14].”
BackgroundStaphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
“Early surgical intervention is extremely important, particularly in cases of streptococcal TSS (20, 45, 91, 92, 211, 213, 219, 292) and cases of staphylococcal necrotizing fasciitis (215, 216).”
BackgroundBoyle-Vavra, S., & Daum, R. S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700501 · Cited by 538
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 512
Modulation of eDNA Release and Degradation Affects Staphylococcus aureus Biofilm Maturation
Mann, E. E., Rice, K. C., Boles, B. R., Endres, J. L., Ranjit, D., Chandramohan, L., Tsang, L. H., Smeltzer, M. S., Horswill, A. R., & Bayles, K. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005822 · Cited by 509
National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft-Tissue Infections
Hersh, A. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1585 · Cited by 501
“Previous studies have suggested that CA-MRSA may be more virulent than other strains of S aureus, leading to more severe disease that requires hospitalization.(20,25) Although we detected an increased number of hospitalizations for SSTIs coincident with the emergence of CA-MRSA, the proportion of ED visits for SSTIs t…”
BackgroundNuclease Expression by Staphylococcus aureus Facilitates Escape from Neutrophil Extracellular Traps
Berends, E. T. M., Horswill, A. R., Haste, N. M., Monestier, M., Nizet, V., & von Köckritz-Blickwede, M. (2010) · Journal of Innate Immunity · doi:10.1159/000319909 · Cited by 487
Murayama, K. M. (2007) · Cited by 477
Hakkarainen, T. W., Kopari, N. M., Pham, T. N., & Evans, H. L. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2014.06.001 · Cited by 460
Shallcross, L. J., Fragaszy, E., Johnson, A. M., & Hayward, A. C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70238-4 · Cited by 463
New epidemiology of Staphylococcus aureus infection in Asia
Chen, C.-J., & Huang, Y.-C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12705 · Cited by 447
“have been reported [88,89,94,95].”
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Stevens, D. L., Ma, Y., Salmi, D. B., McIndoo, E., Wallace, R. J., & Bryant, A. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/510396 · Cited by 452
“PVL causes tissue necrosis in experimental animals [33] and has been implicated, at least epidemiologically, in severe infections in humans, such as necrotizing fasciitis and necrotizing pneumonia [7, 8, 19, 34]; at present, however, no data exist that define a role for PVL in the pathogenesis of CA-MRSA infections.”
BackgroundCraven, R. R., Gao, X., Allen, I. C., Gris, D., Wardenburg, J. B., McElvania-TeKippe, E., Ting, J. P., & Duncan, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007446 · Cited by 433
“very high mortality rates even in previously healthy patients [2,3].”
BackgroundCommunity-Associated MRSA — Resistance and Virulence Converge
Chambers, H. F. (2005) · New England Journal of Medicine · doi:10.1056/nejme058023 · Cited by 423
Diep, B. A., Stone, G. G., Basuino, L., Graber, C. J., Miller, A., Etages, S. D., Jones, A., Palazzolo‐Ballance, A. M., Perdreau‐Remington, F., Sensabaugh, G. F., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587907 · Cited by 422
“Third, a molecular genetic basis for the epidemicity of USA300 [8, 21–35] could be explained by the interconnection between selection for antibiotic resistance and selection for pathogenicity.”
BackgroundSelf-citationSkin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus
Daum, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070747 · Cited by 417
McClure, J.-A., Conly, J. M., Lau, V., Elsayed, S., Louie, T., Hutchins, W., & Zhang, K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.1141-1144.2006 · Cited by 406
Neutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
Neutrophil apoptosis and the resolution of infection
Kennedy, A. D., & DeLeo, F. R. (2009) · Immunologic Research · doi:10.1007/s12026-008-8049-6 · Cited by 400
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., Chambers, H. F., Lu, Y., & Otto, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900743106 · Cited by 394
“This is consistent with the reported potential of USA300 to cause severe and widespread disease (37, 38).”
ResultNatural products to drugs: daptomycin and related lipopeptide antibiotics
Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393
Diep, B. A., Chambers, H. F., Graber, C. J., Szumowski, J. D., Miller, L. G., Han, L. L., Chen, J. H., Lin, F., Lin, J., Phan, T. H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00204 · Cited by 391
Self-citationVieira, F., Allen, S. M., Stocks, R. M. S., & Thompson, J. W. (2008) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2008.01.002 · Cited by 365
Antimicrobial-resistant bacteria in the community setting
Furuya, E. Y., & Lowy, F. D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1325 · Cited by 386
“More severe infections such as necrotizing pneumonia , necrotizing fasciitis and sepsis have also been reporte”
BackgroundCommunity-associated MRSA: What makes them special?
Otto, M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.007 · Cited by 379
“Factor Role Presence Remarks Virulence Alpha-toxin Cytolysin, proInflammatory All CA-MRSA Increased Expression compared to HAMRSA Affects outcome of CA-MRSA pneumonia, skin Infection PSMα peptides (PSMα1 - PSMα4) Cytolysins, leukocidins, proInflammatory All CA-MRSA Increased Expression compared to HAMRSA Affects outco…”
ResultInfluentialPopovich, K. J., Weinstein, R. A., & Hota, B. (2008) · Clinical Infectious Diseases · doi:10.1086/528716 · Cited by 378
“Cases of fulminant infections due to CA MRSA have been described [11, 29].”
BackgroundArnold, S. R., Elias, D., Buckingham, S. C., Thomas, E. D., Novais, E., Arkader, A., & Howard, C. (2006) · Journal of Pediatric Orthopaedics · doi:10.1097/01.bpo.0000242431.91489.b4 · Cited by 358
“White 8 (17) 11 (52)† 2 (25) 2 (50) 1 (33) 5 (83) 27 (39)”
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
Khameneh, B., Diab, R., Ghazvini, K., & Fazly Bazzaz, B. S. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.009 · Cited by 345
Kennedy, A. D., Wardenburg, J. B., Gardner, D. J., Long, D., Whitney, A. R., Braughton, K. R., Schneewind, O., & DeLeo, F. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/656043 · Cited by 335
“Hla and USA300 Skin Infections • JID 2010:202 (1 October) • 1057 sue infections in humans [25].”
BackgroundBacterial Infections in Drug Users
Gordon, R. J., & Lowy, F. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042823 · Cited by 329
The role of virulence determinants in community-associated MRSA pathogenesis
Diep, B. A., & Otto, M. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.05.002 · Cited by 328
“The pandemic clone USA300 has been implicated in unusually severe human diseases, including endocarditis, pneumonia, sepsis, and necrotizing fasciitis [16,17,29].”
BackgroundMethodMiller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318
Self-citationStaphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory Care
McCaig, L. F., McDonald, L. C., Mandal, S., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.060190 · Cited by 307
“Many reports of CA-MRSA skin and soft tissue infections have been documented in either closed populations with frequent skin-to-skin contact (22–25) or emergency department patients and patients admitted through an emergency department (4,8,25).”
BackgroundDiep, B. A., Carleton, H. A., Chang, R. F., Sensabaugh, G. F., & Perdreau‐Remington, F. (2006) · The Journal of Infectious Diseases · doi:10.1086/503777 · Cited by 310
“Unlike ST8:USA500, which causes sporadic disease, ST8:USA300 is epidemic in community populations in at least 16 US states [6, 10–12] and has been linked to clusters of necrotizing fasciitis [1], necrotizing pneumonia [13], and other rapidly progressing and life-threatening staphylococcal infections [14].”
BackgroundSelf-citationCommunity-acquired methicillin-resistant Staphylococcus aureus
Elston, D. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.04.018 · Cited by 308
The importance of the development of antibiotic resistance in Staphylococcus aureus
Schito, G. C. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01343.x · Cited by 302
Laupland, K. B., Ross, T., & Gregson, D. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/589717 · Cited by 296
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
“Risk factors include IV drug use, diabetes, cancer, and HIV/AIDS [80].”
BackgroundAntimicrobial peptides: new hope in the war against multidrug resistance
Mwangi, J., Hao, X., Lai, R., & Zhang, Z.-Y. (2019) · Zool. Res. · doi:10.24272/j.issn.2095-8137.2019.062 · Cited by 289
“…methicillin-resistant S. aureus (MRSA), vancomycin-resistant MRSA, MDR P. aeruginosa, carbapenem-resistant A. baumannii, E. coli, and K. pneumoniae, vancomycin-resistant enterococci (VRE), and extensively drug-resistant (XDR) Mycobacterium tuberculosis (Levin et al., 1999; Miller et al., 2005).”
Diagnosis and management of necrotising fasciitis: a multiparametric approach
Morgan, M. S. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.01.028 · Cited by 279
Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids
Brown, S., Xia, G., Luhachack, L. G., Campbell, J., Meredith, T. C., Chen, C., Winstel, V., Gekeler, C., Irazoqui, J. E., Peschel, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209126109 · Cited by 290
Laupland, K. B., Collaborative, F. T. I. B. S., Lyytikäinen, O., Sgaard, M., Kennedy, K. J., Knudsen, J. D., Ostergaard, C., Galbraith, J. C., Valiquette, L., Jacobsson, G., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03903.x · Cited by 284
Staphylococcus aureus Sepsis and the Waterhouse–Friderichsen Syndrome in Children
Adem, P. V., Montgomery, C. P., Husain, A. N., Koogler, T. K., Arangelovich, V., Humilier, M., Boyle-Vavra, S., & Daum, R. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044194 · Cited by 279
Boyle-Vavra, S., Ereshefsky, B., Wang, C.-C., & Daum, R. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4719-4730.2005 · Cited by 276
“Clinical syndromes caused by these CAMRSA isolates have ranged from skin and soft tissue infections (SSTIs) to necrotizing pneumonia (1, 4, 9, 12, 25, 33), severe sepsis (1, 4, 25), and necrotizing fasciitis ( 24 ).”
BackgroundInfluentialMicrobiology of the skin and the role of biofilms in infection
Percival, S. L., Emanuel, C., Cutting, K. F., & Williams, D. W. (2012) · International Wound Journal · doi:10.1111/j.1742-481x.2011.00836.x · Cited by 271
Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases
Orchard, A., & van Vuuren, S. (2017) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2017/4517971 · Cited by 262
Evaluation and Management of Necrotizing Soft Tissue Infections
Bonne, S. L., & Kadri, S. S. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.011 · Cited by 267
Stryjewski, M. E., & Chambers, H. F. (2008) · Clinical Infectious Diseases · doi:10.1086/533593 · Cited by 268
“CA-MRSA strains can produce a variety of SSTIs, ranging from impetigo to life-threatening necrotizing fasciitis (table 1) [46, 66].”
BackgroundKebaier, C., Chamberland, R. R., Allen, I. C., Gao, X., Broglie, P. M., Hall, J. D., Jania, C., Doerschuk, C. M., Tilley, S. L., & Duncan, J. A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir846 · Cited by 257
“mortality rates, even in previously healthy patients [2, 3].”
BackgroundHighlander, S. K., Hultén, K. G., Qin, X., Jiang, H., Yerrapragada, S., Mason, E. O., Shang, Y., Williams, T. M., Fortunov, R. M., Liu, Y., et al. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-99 · Cited by 262
“In the United States, two clones, USA300 and USA400 have been associated with the majority of CAMRSA infections [7].”
ResultSerious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
“These infections have included necrotizing pneumonia [7], necrotizing fasciitis [8], severe sepsis [9], and Waterhouse-Friderichsen syndrome (characterized by petechial rash, coagulopathy, and cardiovascular collapse) [10].”
BackgroundSelf-citationCommunity‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives
Kluytmans-VandenBergh, M. F. Q., & Kluytmans, J. A. J. W. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01341.x · Cited by 243
Pantosti, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00127 · Cited by 239
“CA-MRSA commonly causes SSTIs with different severity degrees, from mild (furuncles or impetigo), to serious infections (necrotizing fasciitis; Miller et al., 2005), and rarely can cause a severe form of pneumonia (necrotizing pneumonia) associated with high mortality (Francis et al., 2005).”
BackgroundPannaraj, P. S., Hulten, K. G., Gonzalez, B. E., Mason, Jr., & Kaplan, S. L. (2006) · Clinical Infectious Diseases · doi:10.1086/507637 · Cited by 242
“The frequency of isolation of this clone has increased since 2000 at our institution and throughout the United States, indicating that it may have a selective advantage for becoming the predominant community pathogen [11, 12, 26-28].”
BackgroundMethicillin-Resistant Staphylococcus aureus in Animals
Weese, J. S. (2010) · ILAR Journal · doi:10.1093/ilar.51.3.233 · Cited by 239
Rashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521305 · Cited by 232
Gorwitz, R. J., Jernigan, D. B., Powers, J. H., & Jernigan, J. A. (2006) · Cited by 283
Transcription Profiling of the mgrA Regulon in Staphylococcus aureus
Luong, T. T., Dunman, P. M., Murphy, E., Projan, S. J., & Lee, C. Y. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.5.1899-1910.2006 · Cited by 229
Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children
Gonzalez, B. E., Teruya, J., Mahoney, D. H., Hulten, K. G., Edwards, R., Lamberth, L. B., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2006) · Pediatrics · doi:10.1542/peds.2005-2009 · Cited by 225
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia
Chuang, Y.-Y., & Huang, Y.-C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70136-1 · Cited by 219
Gilmer, D. B., Schmitz, J. E., Euler, C. W., & Fischetti, V. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02526-12 · Cited by 216
“CA-MRSA strains are often more virulent and are capable of causing more severe diseases (14, 15).”
BackgroundMolecular Pathogenesis of Staphylococcus aureus Infection
Liu, G. Y. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819dc44d · Cited by 220
D’Agata, E. M. C., Webb, G. F., Horn, M. A., Moellering, Jr., & Ruan, S. (2009) · Clinical Infectious Diseases · doi:10.1086/595844 · Cited by 218
“These infections are associated with longer LOS and, therefore, result in greater exposure to the reservoirs of CA-MRSA [9–11].”
BackgroundRajendran, P. M., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P., & Harris, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00377-07 · Cited by 214
“In a recent survey of MRSA isolates from this clinic, 91% belonged to the PVL-positive epidemic community clone MRSA USA300 (F. Perdreau-Remington, unpublished data), the most prominent community MRSA clone type in the United States and Canada (4, 23) and one that has been implicated as a cause of very severe infectio…”
BackgroundSelf-citationRuhe, J. J., Smith, N., Bradsher, R. W., & Menon, A. (2007) · Clinical Infectious Diseases · doi:10.1086/511872 · Cited by 214
“Staphylococcus aureus causes skin and soft-tissue infections (SSTIs) that range from folliculitis to life-threatening conditions, such as necrotizing fasciitis [1, 2].”
BackgroundPerlroth, J., Kuo, M., Tan, J., Bayer, A. S., & Miller, L. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.805 · Cited by 212
Self-citationNecrotizing fasciitis: Classification, diagnosis, and management
Lancerotto, L., Tocco, I., Salmaso, R., Vindigni, V., & Bassetto, F. (2012) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e318232a6b3 · Cited by 206
Skin Infections Caused by Staphylococcus aureus
Giudice, P. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3466 · Cited by 182
“(52) reported 14 cases in 2005 caused by CA-MRSA.”
BackgroundThe SaeR/S Gene Regulatory System Is Essential for Innate Immune Evasion by Staphylococcus aureus
Voyich, J. M., Vuong, C., DeWald, M., Nygaard, T. K., Kocianova, S., Griffith, S., Jones, J., Iverson, C., Sturdevant, D. E., Braughton, K. R., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/598967 · Cited by 208
“[2– 6].”
Nordmann, P., Naas, T., Fortineau, N., & Poirel, L. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.07.004 · Cited by 206
Micek, S. T. (2007) · Clinical Infectious Diseases · doi:10.1086/519471 · Cited by 202
“Linezolid should also be considered for necrotizing infections, including skin lesions [12], fasciitis [13], and pneumonia [14] caused by community-associated MRSA, particularly the USA300 strain.”
BackgroundDavis, S. L., Perri, M. B., Donabedian, S. M., Manierski, C., Singh, A., Vager, D., Haque, N. Z., Speirs, K., Muder, R. R., Robinson-Dunn, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02311-06 · Cited by 196
“A number of recent studies have reported a variety of serious infections, including necrotizing fasciitis, pneumonia, and death, as a result of infection with USA300 and USA400 strains (12, 15, 24 ).”
BackgroundInvasive Methicillin-Resistant Staphylococcus aureus Infections in the United States
Kumar, A. (2008) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(08)70527-6 · Cited by 197
Community-acquired methicillin-resistant Staphylococcus aureus infections
Maltezou, H. C., & Giamarellou, H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.004 · Cited by 197
Treatment of Staphylococcus aureus Infections
David, M. Z., & Daum, R. S. (2017) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2017_42 · Cited by 185
“aureus has been recorded in many case reports and case series as the sole pathogen (Chhetry et al. 2016; de Carvalho et al. 2012; Miller et al. 2005; Perbet et al. 2010; Thapaliya et al. 2015; Tsitsilonis et al. 2013; Wood 2015; Young and Price 2008) after the emergence of CA-MRSA.”
Background
Metadata
- Authors
- Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B.
- Affiliations
- University of California, Los Angeles (US)
- St. Mary Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-07
- Volume
- 352
- Issue
- 14
- Pages
- 1445-1453
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150907717
- Cited by
- 1,053
- References
- 62
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 17 · 2023: 20 · 2022: 31 · 2021: 16 · 2020: 34 · 2019: 28 · 2018: 16 · 2017: 26 · 2016: 39 · 2015: 44 · 2014: 47 · 2013: 44 · 2012: 65
- FWCI
- 72.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (R01/CCR923417-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- necrotizing fasciitis, community-associated methicillin-resistant Staphylococcus aureus, necrotizing myositis, intravenous drug use, ST8, USA300, Panton-Valentine leukocidin, empirical antibiotic therapy, Los Angeles
- MeSH terms
- Adult, Aged, DNA, Bacterial, Female, Genes, Bacterial, Genotype, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Bacterial Typing Techniques, Methicillin Resistance, Bacteremia, Community-Acquired Infections, Fasciitis, Necrotizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.